Parra, G. A., Lindarte, H. H. and Rubio, A. F. (2020) “Over optimum response to PCSK-9 inhibitors: ¿is it mandatory to supply them every 2 weeks?, about a case”, Revista Colombiana de Endocrinología, Diabetes & Metabolismo, 7(1), pp. 43–44. doi: 10.53853/encr.7.1.568.